Uncoupling by (-)-epigallocatechin-3-gallate of ATP-sensitive potassium channels from phosphatidylinositol polyphosphates and ATP

Pharmacological Research

Volumn 56, Issue 3, 2007, Pages 237-247

  Jin, Jun Yup ^a   Park, Sung Hee ^a   Bae, Jae Hoon ^a   Cho, Ho Chan ^a   Lim, Jeong Geun ^a   Park, Won Sun ^b   Han, Jin ^b   Lee, Jin Ho ^c   Song, Dae Kyu ^a  

^a Keimyung University School of Medicine   (South Korea)

^b Inje University   (South Korea)

^c Keimyung University   (South Korea)

Author keywords

ATP sensitive potassium channel; Cardiomyocyte; Epicatechin; Insulin secretion; Phosphatidylinositol polyphosphate

Indexed keywords

ADENOSINE TRIPHOSPHATE; ADENOSINE TRIPHOSPHATE SENSITIVE POTASSIUM CHANNEL; CYTOSOL RECEPTOR; EPICATECHIN GALLATE; EPIGALLOCATECHIN GALLATE; INWARDLY RECTIFYING POTASSIUM CHANNEL SUBUNIT KIR6.2; NEOMYCIN; POLYPHOSPHOINOSITIDE; SULFONYLUREA RECEPTOR; UNCOUPLING PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD LEVEL; CONTROLLED STUDY; FEMALE; HEART MUSCLE CELL; INSULIN RELEASE; MODULATION; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; RAT; SENSITIVITY AND SPECIFICITY; XENOPUS LAEVIS;

ADENOSINE TRIPHOSPHATE; ANIMALS; ATP-BINDING CASSETTE TRANSPORTERS; BLOOD GLUCOSE; CALCIUM; CATECHIN; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; INSULIN; INSULIN-SECRETING CELLS; ION CHANNEL GATING; MALE; MEMBRANE POTENTIALS; MICE; MOLECULAR STRUCTURE; MULTIDRUG RESISTANCE-ASSOCIATED PROTEINS; MYOCYTES, CARDIAC; NEOMYCIN; OOCYTES; PHOSPHATIDYLINOSITOL PHOSPHATES; POTASSIUM CHANNEL BLOCKERS; POTASSIUM CHANNELS; POTASSIUM CHANNELS, INWARDLY RECTIFYING; RABBITS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, DRUG; STRUCTURE-ACTIVITY RELATIONSHIP; XENOPUS LAEVIS;

EID: 34548217794     PISSN: 10436618     EISSN: 10961186     Source Type: Journal    
DOI: 10.1016/j.phrs.2007.06.004     Document Type: Article

References (42)

1. Qanungo S., Das M., Haldar S., and Basu A. Epigallocatechin-3-gallate induces mitochondrial membrane depolarization and caspase-dependent apoptosis in pancreatic cancer cells. Carcinogenesis 26 (2005) 958-967
2. Arts I.C., Hollman P.C., Feskens E.J., Bueno de Mesquita H.B., and Kromhout D. Catechin intake might explain the inverse relation between tea consumption and ischemic heart disease: the Zutphen Elderly Study. Am J Clin Nutr 74 (2001) 227-232
3. Miura Y., Chiba T., Tomita I., Koizumi H., Miura S., Umegaki K., Hara Y., Ikeda M., and Tomita T. Tea catechins prevent the development of atherosclerosis in apoprotein E-deficient mice. J Nutr 131 (2001) 27-32
4. Kao Y.H., Hiipakka R.A., and Liao S. Modulation of endocrine systems and food intake by green tea epigallocatechin gallate. Endocrinology 141 (2000) 980-987
5. Fiorini R.N., Donovan J.L., Rodwell D., Evans Z., Cheng G., May H.D., Milliken C.E., Markowitz J.S., Campbell C., Haines J.K., Schmidt M.G., and Chavin K.D. Short-term administration of (-)-epigallocatechin gallate reduces hepatic steatosis and protects against warm hepatic ischemia/reperfusion injury in steatotic mice. Liver Transpl 11 (2005) 298-308
6. Lu H., Meng X., and Yang C.S. Enzymology of methylation of tea catechins and inhibition of catechol-O-methyltransferase by (-)-epigallocatechin gallate. Drug Metab Dispos 31 (2003) 572-579
7. Ichikawa D., Matsui A., Imai M., Sonoda Y., and Kasahara T. Effect of various catechins on the IL-12p40 production by murine peritoneal macrophages and a macrophage cell line, J774.1. Biol Pharm Bull 27 (2004) 1353-1358
8. Lin Y.L., and Lin J.K. (-)-Epigallocatechin-3-gallate blocks the induction of nitric oxide synthase by down-regulating lipopolysaccharide-induced activity of transcription factor nuclear factor-kappaB. Mol Pharmacol 52 (1997) 465-472
9. Kawai K., Tsuno N.H., Kitayama J., Okaji Y., Yazawa K., Asakage M., Hori N., Watanabe T., Takahashi K., and Nagawa H. Epigallocatechin gallate, the main component of tea polyphenol, binds to CD4 and interferes with gp120 binding. J Allergy Clin Immunol 112 (2003) 951-957
10. Hirasawa M., and Takada K. Multiple effects of green tea catechin on the antifungal activity of antimycotics against Candida albicans. J Antimicrob Chemother 53 (2004) 225-229
11. Xia J., Song X., Bi Z., Chu W., and Wan Y. UV-induced NF-kappaB activation and expression of IL-6 is attenuated by (-)-epigallocatechin-3-gallate in cultured human keratinocytes in vitro. Int J Mol Med 16 (2005) 943-950
12. Yun S.Y., Kim S.P., and Song D.K. Effects of (-)-epigallocatechin-3-gallate on pancreatic beta-cell damage in streptozotocin-induced diabetic rats. Eur J Pharmacol 541 (2006) 115-121
13. Hwang J.T., Park I.J., Shin J.I., Lee Y.K., Lee S.K., Baik H.W., Ha J., and Park O.J. Genistein EGCG, and capsaicin inhibit adipocyte differentiation process via activating AMP-activated protein kinase. Biochem Biophys Res Commun 338 (2005) 694-699
14. Garbisa S., Sartor L., Biggin S., Salvato B., Benelli R., and Albini A. Tumor gelatinases and invasion inhibited by the green tea flavanol epigallocatechin-3-gallate. Cancer 91 (2001) 822-832
15. Kuzuhara T., Sei Y., Yamaguchi K., Suganuma M., and Fujiki H. DNA and RNA as new binding targets of green tea catechins. J Biol Chem 281 (2006) 17446-17456
16. Baek W.K., Jang B.C., Lim J.H., Kwon T.K., Lee H.Y., Cho C.H., Kim D.K., Shin D.H., Park J.G., Lim J.G., Bae J.H., Yoo S.K., Park W.K., and Song D.K. Inhibitory modulation of ATP-sensitive potassium channels by gallate-ester moiety of (-)-epigallocatechin-3-gallate. Biochem Pharmacol 70 (2005) 1560-1567
17. + channels inhibits adhesion and proliferation of hepatocarcinoma cells. Int J Mol Med 11 (2003) 261-266
18. Chow H.H., Hakim I.A., Vining D.R., Crowell J.A., Ranger-Moore J., Chew W.M., Celaya C.A., Rodney S.R., Hara Y., and Alberts D.S. Effects of dosing condition on the oral bioavailability of green tea catechins after single-dose administration of Polyphenon E in healthy individuals. Clin Cancer Res 11 (2005) 4627-4633
19. Lee M.J., Maliakal P., Chen L., Meng X., Bondoc F.Y., Prabhu S., Lambert G., Mohr S., and Yang C.S. Pharmacokinetics of tea catechins after ingestion of green tea and (-)-epigallocatechin-3-gallate by humans: formation of different metabolites and individual variability. Cancer Epidemiol Biomarkers Prev 11 (2002) 1025-1032
20. Hagiwara M., Inoue S., Tanaka T., Nunoki K., Ito M., and Hidaka H. Differential effects of flavonoids as inhibitors of tyrosine protein kinases and serine/threonine protein kinases. Biochem Pharmacol 37 (1988) 2987-2992
21. ATP channel subunit Kir6.2. J Physiol 557 Pt 2 (2004) 347-354
22. Trapp S., Haider S., Jones P., Sansom M.S., and Ashcroft F.M. Identification of residues contributing to the ATP binding site of Kir6.2. EMBO J 22 (2003) 2903-2912
23. ATP channel Kir6.2 subunit. EMBO J 24 (2005) 229-239
24. ATP channel-deficient mice. Proc Natl Acad Sci USA 95 (1998) 10402-10406
25. Wang R., Liu X., Hentges S.T., Dunn-Meynell A.A., Levin B.E., Wang W., and Routh V.H. The regulation of glucose-excited neurons in the hypothalamic arcuate nucleus by glucose and feeding-relevant peptides. Diabetes 53 (2004) 1959-1965
26. Gumina R.J., Pucar D., Bast P., Hodgson D.M., Kurtz C.E., Dzeja P.P., Miki T., Seino S., and Terzic A. Knockout of Kir6.2 negates ischemic preconditioning-induced protection of myocardial energetics. Am J Physiol Heart Circ Physiol 284 (2003) H2106-H2113
27. Ashcroft F.M. ATP-sensitive potassium channelopathies: focus on insulin secretion. J Clin Invest 115 (2005) 2047-2058
28. + channels: role of the gamma phosphate group of ATP and the R50 residue of mouse Kir6.2. J Physiol 568 Pt 3 (2005) 931-940
29. Song D.K., and Ashcroft F.M. ATP modulation of ATP-sensitive potassium channel ATP sensitivity varies with the type of SUR subunit. J Biol Chem 276 (2001) 7143-7149
30. Inagaki N., Gonoi T., Clement J.P., Namba N., Inazawa J., Gonzalez G., Aguilar-Bryan L., Seino S., and Bryan J. Reconstitution of IKATP: an inward rectifier subunit plus the sulfonylurea receptor. Science 270 (1995) 1166-1170
31. Aguilar-Bryan L., Nichols C.G., Wechsler S.W., Clement J.Pt., Boyd III A.E., Gonzalez G., Herrera-Sosa H., Nguy K., Bryan J., and Nelson D.A. Cloning of the beta cell high-affinity sulfonylurea receptor: a regulator of insulin secretion. Science 268 (1995) 423-426
32. + channels. Neuron 16 (1996) 1011-1017
33. + channel. J Biol Chem 271 (1996) 24321-24324
34. ATP channel by interaction with its SUR1 subunit. Proc Natl Acad Sci USA 95 (1998) 7185-7190
35. Han J., Bae J.H., Kim S.Y., Lee H.Y., Jang B.C., Lee I.K., Cho C.H., Lim J.G., Suh S.I., Kwon T.K., Park J.W., Ryu S.Y., Ho W.K., Earm Y.E., and Song D.K. Taurine increases glucose sensitivity of UCP2-overexpressing beta-cells by ameliorating mitochondrial metabolism. Am J Physiol Endocrinol Metab 287 (2004) E1008-E1018
36. Han J., Kim N., Kim E., Ho W.K., and Earm Y.E. Modulation of ATP-sensitive potassium channels by cGMP-dependent protein kinase in rabbit ventricular myocytes. J Biol Chem 276 (2001) 22140-22147
37. ATP channels. Science 282 (1998) 1138-1141
38. + channels: regulation of bursting by the sulphonylurea receptor, PIP2 and regions of Kir6.2. J Physiol 571 Pt 2 (2006) 303-317
39. + channel. A molecular probe for the mechanism of ATP-sensitive inhibition. J Gen Physiol 114 (1999) 251-269
40. Kajiya K., Kumazawa S., and Nakayama T. Steric effects on interaction of tea catechins with lipid bilayers. Biosci Biotechnol Biochem 65 (2001) 2638-2643
41. ATP channel complex Kir6.2-SUR1. EMBO J 24 (2005) 4166-4175
42. Youdim M.B. What have we learnt from CDNA microarray gene expression studies about the role of iron in MPTP induced neurodegeneration and Parkinson's disease?. J Neural Transm 65 (2003) S73-S88